Targeted agents for HER2-positive breast cancer in older adults: current and future perspectives.
Enrique Soto Pérez de CelisKah Poh LohCapucine BaldiniNicolò Matteo Luca BattistiYanin Chavarri GuerraNienke A De GlasTina HsuArti HurriaPublished in: Expert opinion on investigational drugs (2018)
Older adults are underrepresented in trials of HER2-targeted therapies in BC. We propose strategies to increase recruitment of older adults in clinical trials in order to increase the evidence base to treat this growing population.